Sky View Investment Advisors, LLC Csl LTD Transaction History

Sky View Investment Advisors, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	BUY	$86.82 - $98.5 $4,514 - $5,122	52 Added 0.65%	8,067 $795,000
Q1 2024 May 15, 2024	BUY	$89.91 - $99.41 $720,628 - $796,771	8,015 New	8,015 $756,000
Q3 2023 Nov 16, 2023	BUY	$80.15 - $92.62 $26,128 - $30,194	326 Added 5.15%	6,662 $538,000
Q2 2023 Aug 15, 2023	SELL	$91.49 - $104.64 $13,174 - $15,068	-144 Reduced 2.22%	6,336 $585,000
Q1 2023 May 18, 2023	BUY	$92.92 - $109.35 $101,840 - $119,847	1,096 Added 20.36%	6,480 $626,000
Q4 2022 Feb 16, 2023	SELL	$84.9 - $102.89 $67,495 - $81,797	-795 Reduced 12.87%	5,384 $525,000
Q3 2022 Nov 16, 2022	BUY	$90.51 - $207.38 $89,966 - $206,135	994 Added 19.17%	6,179 $564,000
Q2 2022 Nov 15, 2022	SELL	$87.94 - $101.67 $2,638 - $3,050	-30 Reduced 0.58%	5,185 $477,000
Q1 2022 May 17, 2022	SELL	$85.56 - $107.12 $51,678 - $64,700	-604 Reduced 10.38%	5,215 $520,000
Q4 2021 Feb 18, 2022	BUY	$97.41 - $116.74 $173,584 - $208,030	1,782 Added 44.14%	5,819 $488,000
Q3 2021 Nov 16, 2021	BUY	$101.72 - $114.56 $407,897 - $459,385	4,010 Added 14851.85%	4,037 $423,000
Q4 2020 Mar 02, 2021	BUY	$101.34 - $117.74 $2,736 - $3,178	27 New	27 $3,000

153K

Ticker CSLLY
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 964,432,000
Market Cap $84.7B
Description
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plas...

Get notified when there are updates to the investment portfolio of Sky View Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Sky View Investment Advisors, LLC with notifications on news.